Insights in Pathology & Oncology | 2025

Articles

REVIEW

Published on 02 Mar 2026

Prognostic and predictive factors of immune checkpoint inhibitor therapy in urinary bladder cancer

Melinda Váradi
Balázs Magyar
Ádám Széles
Sára Korda
Bernadett Németh
Barbara Simon
Henning Reis
Csilla Oláh
Orsolya Horváth
2 more
Tibor Szarvas

doi 10.3389/pore.2026.1612333

COMMENTARY

Published on 27 Jan 2026

Commentary: CVM-1118 (foslinanib), a 2-phenyl-4-quinolone derivative, promotes apoptosis and inhibits vasculogenic mimicry via targeting TRAP1

Mary J. C. Hendrix
Elisabeth A. Seftor
Richard E. B. Seftor
Yi-Wen Chu
Du-Shieng Chien
Yen-Ling Chen

doi 10.3389/pore.2026.1612325

Share on

Pathology and Oncology Research

Pathology and Oncology Research